Effects of manganese on tyrosine hydroxylase (TH) activity and TH-phosphorylation in a dopaminergic neural cell line

Toxicology and Applied Pharmacology

Volumn 254, Issue 2, 2011, Pages 65-71

  Zhang, Danhui ^a   Kanthasamy, Arthi ^a   Anantharam, Vellareddy ^a   Kanthasamy, Anumantha ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Dopamine synthesis; Manganese; Neurotoxicity; Parkinson's disease; Phosphorylation; Protein kinase C

Indexed keywords

DOPAMINE; MANGANESE; MANGANESE CHLORIDE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE C DELTA; ROTTLERIN; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; NEUROTOXICITY; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DOPAMINE; ENZYME ACTIVATION; MANGANESE; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; PROTEIN PHOSPHATASE 2; TYROSINE 3-MONOOXYGENASE;

EID: 79959978837     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2010.03.023     Document Type: Article

References (50)

1. Adams F.S., La Rosa F.G., Kumar S., Edwards-Prasad J., Kentroti S., Vernadakis A., Freed C.R., Prasad K.N. Characterization and transplantation of two neuronal cell lines with dopaminergic properties. Neurochem. Res. 1996, 21:619-627.
2. Afeseh Ngwa H., Kanthasamy A., Anantharam V., Song C., Witte T., Houk R., Kanthasamy A.G. Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease. Toxicol. Appl. Pharmacol. 2009, 240:273-285.
3. Anantharam V., Kaul S., Song C., Kanthasamy A., Kanthasamy A.G. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology 2007, 28:988-997.
4. Anantharam V., Kitazawa M., Latchoumycandane C., Kanthasamy A., Kanthasamy A.G. Blockade of PKCdelta proteolytic activation by loss of function mutants rescues mesencephalic dopaminergic neurons from methylcyclopentadienyl manganese tricarbonyl (MMT)-induced apoptotic cell death. Ann. NY Acad. Sci. 2004, 1035:271-289.
5. Anantharam V., Kitazawa M., Wagner J., Kaul S., Kanthasamy A.G. Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. J. Neurosci. 2002, 22:1738-1751.
6. Aschner J.L., Aschner M. Nutritional aspects of manganese homeostasis. Mol. Aspects Med. 2005, 26:353-362.
7. Aschner M., Lukey B., Tremblay A. The Manganese Health Research Program (MHRP): status report and future research needs and directions. Neurotoxicology 2006, 27:733-736.
8. Baek S.Y., Kim Y.H., Oh S.O., Lee C.R., Yoo C.I., Lee J.H., Lee H., Sim C.S., Park J., Kim J.W., Yoon C.S., Kim Y. Manganese does not alter the severe neurotoxicity of MPTP. Hum. Exp. Toxicol. 2007, 26:203-211.
9. Baek S.Y., Lee M.J., Jung H.S., Kim H.J., Lee C.R., Yoo C., Lee J.H., Lee H., Yoon C.S., Kim Y.H., Park J., Kim J.W., Jeon B.S., Kim Y. Effect of manganese exposure on MPTP neurotoxicities. Neurotoxicology 2003, 24:657-665.
10. Bevilaqua L.R., Cammarota M., Dickson P.W., Sim A.T., Dunkley P.R. Role of protein phosphatase 2C from bovine adrenal chromaffin cells in the dephosphorylation of phospho-serine 40 tyrosine hydroxylase. J. Neurochem. 2003, 85:1368-1373.
11. Campbell D.G., Hardie D.G., Vulliet P.R. Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J. Biol. Chem. 1986, 261:10489-10492.
12. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. NY Acad. Sci. 2004, 1012:115-128.
13. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., Dickson P.W. Tyrosine hydroxylase phosphorylation: regulation and consequences. J. Neurochem. 2004, 91:1025-1043.
14. Ensing J.G. Bazooka: cocaine-base and manganese carbonate. J. Anal. Toxicol. 1985, 9:45-46.
15. Erikson K.M., Thompson K., Aschner J., Aschner M. Manganese neurotoxicity: a focus on the neonate. Pharmacol. Ther. 2007, 113:369-377.
16. Erikson K.M., Dorman D.C., Lash L.H., Aschner M. Duration of airborne-manganese exposure in rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Neurotoxicology 2008, 29:377-385.
17. Fujisawa H., Okuno S. Regulatory mechanism of tyrosine hydroxylase activity. Biochem. Biophys. Res. Commun. 2005, 338:271-276.
18. Goldstein M., Lieberman A. The role of the regulatory enzymes of catecholamine synthesis in Parkinson's disease. Neurology 1992, 42:8-12. discussion 41-18.
19. Gschwendt M. Protein kinase C delta. Eur. J. Biochem. 1999, 259:555-564.
20. Guilarte T.R., Chen M.K., McGlothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., Koser A.J., Fritz S., Gonczi H., Anderson D.W., Schneider J.S. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp. Neurol. 2006, 202:381-390.
21. Guilarte T.R., Burton N.C., McGlothan J.L., Verina T., Zhou Y., Alexander M., Pham L., Griswold M., Wong D.F., Syversen T., Schneider J.S. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J. Neurochem. 2008, 107:1236-1247.
22. Haavik J., Schelling D.L., Campbell D.G., Andersson K.K., Flatmark T., Cohen P. Identification of protein phosphatase 2A as the major tyrosine hydroxylase phosphatase in adrenal medulla and corpus striatum: evidence from the effects of okadaic acid. FEBS Lett. 1989, 251:36-42.
23. Hauser R.A., Zesiewicz T.A., Martinez C., Rosemurgy A.S., Olanow C.W. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can. J. Neurol. Sci. 1996, 23:95-98.
24. Hayashi Y., Miwa S., Lee K., Koshimura K., Kamel A., Hamahata K., Fujiwara M. A nonisotopic method for determination of the in vivo activities of tyrosine hydroxylase in the rat adrenal gland. Anal. Biochem. 1988, 168:176-183.
25. Haycock J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem. 1990, 265:11682-11691.
26. Haycock J.W., Ahn N.G., Cobb M.H., Krebs E.G. ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl. Acad. Sci. USA 1992, 89:2365-2369.
27. Hirata Y., Furuta K., Miyazaki S., Suzuki M., Kiuchi K. Anti-apoptotic and pro-apoptotic effect of NEPP11 on manganese-induced apoptosis and JNK pathway activation in PC12 cells. Brain Res. 2004, 1021:241-247.
28. Kanthasamy A.G., Kitazawa M., Kanthasamy A., Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid. Redox Signal. 2003, 5:609-620.
29. Kaul S., Kanthasamy A., Kitazawa M., Anantharam V., Kanthasamy A.G. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur. J. Neurosci. 2003, 18:1387-1401.
30. Kitazawa M., Anantharam V., Kanthasamy A.G. Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells. Free Radic. Biol. Med. 2001, 31:1473-1485.
31. Kitazawa M., Wagner J.R., Kirby M.L., Anantharam V., Kanthasamy A.G. Oxidative stress and mitochondrial-mediated apoptosis in dopaminergic cells exposed to methylcyclopentadienyl manganese tricarbonyl. J. Pharmacol. Exp. Ther. 2002, 302:26-35.
32. Krieger D., Krieger S., Jansen O., Gass P., Theilmann L., Lichtnecker H. Manganese and chronic hepatic encephalopathy. Lancet. 1995, 346:270-274.
33. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y., Kanthasamy A., Kanthasamy A.G. Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J. Pharmacol. Exp. Ther. 2005, 313:46-55.
34. Lee K.Y., Lew J.Y., Tang D., Schlesinger D.H., Deutch A.Y., Goldstein M. Antibodies to a synthetic peptide corresponding to a Ser-40-containing segment of tyrosine hydroxylase: activation and immunohistochemical localization of tyrosine hydroxylase. J. Neurochem. 1989, 53:1238-1244.
35. Liu X., Sullivan K.A., Madl J.E., Legare M., Tjalkens R.B. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci. 2006, 91:521-531.
36. Lucchini R., Apostoli P., Perrone C., Placidi D., Albini E., Migliorati P., Mergler D., Sassine M.P., Palmi S., Alessio L. Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-297.
37. McKinney A.M., Filice R.W., Teksam M., Casey S., Truwit C., Clark H.B., Woon C., Liu H.Y. Diffusion abnormalities of the globi pallidi in manganese neurotoxicity. Neuroradiology 2004, 46:291-295.
38. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann. NY Acad. Sci. 2004, 1012:209-223.
39. Perl D.P., Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J. Neuropathol. Exp. Neurol. 2007, 66:675-682.
40. Posser T., Franco J.L., Bobrovskaya L., Leal R.B., Dickson P.W., Dunkley P.R. Manganese induces sustained Ser40 phosphorylation and activation of tyrosine hydroxylase in PC12 cells. J. Neurochem. 2009, 110:848-856.
41. Reyland M.E. Protein kinase Cdelta and apoptosis. Biochem. Soc. Trans. 2007, 35:1001-1004.
42. Roth J.A., Garrick M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem. Pharmacol. 2003, 66:1-13.
43. Stredrick D.L., Stokes A.H., Worst T.J., Freeman W.M., Johnson E.A., Lash L.H., Aschner M., Vrana K.E. Manganese-induced cytotoxicity in dopamine-producing cells. Neurotoxicology 2004, 25:543-553.
44. Sun F., Anantharam V., Zhang D., Latchoumycandane C., Kanthasamy A., Kanthasamy A.G. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models. Neurotoxicology 2006, 27:807-815.
45. Wang J., Lou H., Pedersen C.J., Smith A.D., Perez R.G. 14-3-3zeta contributes to tyrosine hydroxylase activity in MN9D cells: localization of dopamine regulatory proteins to mitochondria. J. Biol. Chem. 2009, 284:14011-14019.
46. Woolf A., Wright R., Amarasiriwardena C., Bellinger D. A child with chronic manganese exposure from drinking water. Environ. Health Perspect. 2002, 110:613-616.
47. Wu J., Filer D., Friedhoff A.J., Goldstein M. Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. J. Biol. Chem. 1992, 267:25754-25758.
48. Xing Y., Li Z., Chen Y., Stock J.B., Jeffrey P.D., Shi Y. Structural mechanism of demethylation and inactivation of protein phosphatase 2A. Cell 2008, 133:154-163.
49. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., Giaveri G., Arosio P., Santambrogio P., Fariello R.G., Karatekin E., Kleinman M.H., Turro N., Hornykiewicz O., Zucca F.A. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. USA 2004, 101:9843-9848.
50. Zhang D., Kanthasamy A., Yang Y., Anantharam V. Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons. J. Neurosci. 2007, 27:5349-5362.